Blood vessels engineered from human cells
- PMID: 15964449
- DOI: 10.1016/S0140-6736(05)66735-9
Blood vessels engineered from human cells
Abstract
Tissue engineering has made considerable progress in the past decade, but advances have stopped short of clinical application for most tissues. We postulated that an obstacle in engineering human tissues is the limited replicative capacity of adult somatic cells. To test this hypothesis, the effectiveness of telomerase expression to extend cellular lifespan was assessed in a model of human vascular tissue engineering. Telomerase expression in vascular cells isolated from elderly patients enabled the successful culture of engineered autologous blood vessels. Engineered vessels may one day provide a source of bypass conduit for patients with atherosclerotic disease.
Comment in
-
Telomerase expression in somatic cells.Lancet. 2005 Jun 18-24;365(9477):2068-9. doi: 10.1016/S0140-6736(05)66715-3. Lancet. 2005. PMID: 15964429 No abstract available.
-
Blood vessels engineered from human cells.Lancet. 2005 Sep 10-16;366(9489):891-2; author reply 892-3. doi: 10.1016/S0140-6736(05)67311-4. Lancet. 2005. PMID: 16154007 No abstract available.
-
Blood vessels engineered from human cells.Lancet. 2005 Sep 10-16;366(9489):892; author reply 892-3. doi: 10.1016/S0140-6736(05)67312-6. Lancet. 2005. PMID: 16154009 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
